跳至主要内容
临床试验/NCT03695432
NCT03695432已完成4 期

Role of Probiotic and Influenza Vaccination on Immune Response Enchancement and Influenza-Like Illness Incidence Reduction in Elderly

Indonesia University2 个研究点 分布在 1 个国家目标入组 910 人开始时间: 2014年10月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
910
试验地点
2
主要终点
The precentage enhancement of the immune response to flubio vaccine and probiotic compared to plasebo 6 months after vaccination

研究概览

简要总结

To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly

详细描述

To see percetange of subjects seroconvertion and seroprotection before and after intervention in the elderly (>60 years), and monitored for 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all health elderly aged ≥ 60 years
  • who came to the vaccination and health education activities in the entire East Jakarta District Health Center
  • with Body Mass Index (BMI) 17,5-29,9
  • healthy mental status (MMSE score of 28-30)

排除标准

  • subject who have contraindications to influenza vaccinations
  • are undergoing treatment related to immune system modulation in the past 4 weeks
  • therapy for immunossuppresants and/ or corticosteroids eqivalent to prednisone ≥ 20 mg/day that is being lived more than 2 weeks or has only been stopped less than 3 months before the study
  • recieved influenza vaccination less than one year before
  • Currently consuming probiotic agents, either in the form of a manufacturer or natural for more than 7 days.

研究组 & 干预措施

Vaccine

Experimental

Flubio (A/California/7/2009, A/Texas/50/2012 and B/Massachusetts/2/2012) Vaccine 0,5 ml for every subjects The vaccine will be given intramuscularly

干预措施: Flubio (Biological)

Probiotic

Experimental

Lacidofil (Lactobacillus acidophilus Rossel-52 and Lactobacillus rhamnosus Rosell-11 with maltodextrin 211 mg, magnesium stearat 8 mg and ascorbic acid 1 mg) antibiotic

干预措施: Lacidofil (Dietary Supplement)

Placebo Vaccine

Placebo Comparator

Nacl 0,9% 0,5 ml The placebo vaccine will be given intramuscularly

干预措施: Placebo Vaccine (Other)

Placebo probiotic

Placebo Comparator

capsul

干预措施: Placebo probiotic (Other)

结局指标

主要结局

The precentage enhancement of the immune response to flubio vaccine and probiotic compared to plasebo 6 months after vaccination

时间窗: 6 months

次要结局

  • Percentage of subjects with anti HI titer >=1:40(6 months)
  • Percentage subjects with increasing antibody titer >=4 times(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sukamto Koesnoe

Principal investigator

Indonesia University

研究点 (2)

Loading locations...

相似试验